News articles about Align Technology (NASDAQ:ALGN) have trended somewhat positive recently, according to Accern Sentiment. Accern rates the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Align Technology earned a news impact score of 0.08 on Accern’s scale. Accern also gave news stories about the medical equipment provider an impact score of 46.5112467850907 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
These are some of the media headlines that may have impacted Accern Sentiment’s scoring:
- Hot Stock’s Highlights – Align Technology Inc (NASDAQ: ALGN) – Nasdaq Tribune (press release) (nasdaqtribune.com)
- Glowing Stock’s Review – Align Technology Inc (NASDAQ: ALGN) – Alpha Beta Stock (alphabetastock.com)
- Align Technology, Inc. (ALGN) Expected to Post Quarterly Sales of $395.48 Million (americanbankingnews.com)
- Leerink Swann Weighs in on Align Technology, Inc.’s Q1 2018 Earnings (ALGN) (americanbankingnews.com)
- Align Technology (ALGN) Scheduled to Post Quarterly Earnings on Monday (americanbankingnews.com)
Align Technology (ALGN) traded up $5.06 during trading on Tuesday, reaching $272.16. 973,398 shares of the company’s stock were exchanged, compared to its average volume of 1,161,273. The firm has a market cap of $21,820.00, a price-to-earnings ratio of 82.72, a price-to-earnings-growth ratio of 2.11 and a beta of 1.43. Align Technology has a 52-week low of $88.56 and a 52-week high of $276.99.
Align Technology (NASDAQ:ALGN) last issued its quarterly earnings results on Thursday, October 26th. The medical equipment provider reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.82 by $0.19. The company had revenue of $385.30 million during the quarter, compared to analyst estimates of $359.80 million. Align Technology had a net margin of 19.98% and a return on equity of 25.60%. The business’s revenue for the quarter was up 38.3% compared to the same quarter last year. During the same period in the prior year, the business posted $0.63 EPS. sell-side analysts expect that Align Technology will post 3.67 EPS for the current year.
A number of research firms have issued reports on ALGN. Stephens lowered shares of Align Technology from an “overweight” rating to an “equal weight” rating and set a $230.00 target price for the company. in a research note on Friday. Credit Suisse Group reissued an “outperform” rating and set a $276.00 target price (up from $261.00) on shares of Align Technology in a research note on Tuesday, November 28th. Robert W. Baird reissued a “buy” rating and set a $290.00 target price on shares of Align Technology in a research note on Wednesday, November 29th. Stifel Nicolaus boosted their target price on shares of Align Technology from $245.00 to $265.00 and gave the company a “buy” rating in a research note on Tuesday, November 21st. Finally, Morgan Stanley boosted their target price on shares of Align Technology from $257.00 to $300.00 and gave the company an “overweight” rating in a research note on Monday, November 27th. Three research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $236.23.
In other news, Director Joseph Lacob sold 29,724 shares of the company’s stock in a transaction that occurred on Thursday, November 30th. The shares were sold at an average price of $260.91, for a total value of $7,755,288.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Emory Wright sold 5,025 shares of the company’s stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $263.68, for a total transaction of $1,324,992.00. Following the completion of the sale, the vice president now directly owns 80,762 shares of the company’s stock, valued at $21,295,324.16. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 52,849 shares of company stock valued at $13,494,348. Company insiders own 1.60% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece of content was originally published by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.truebluetribune.com/2018/01/23/align-technology-algn-receives-daily-news-sentiment-score-of-0-08.html.
Align Technology Company Profile
Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.